No black box warning on record for Ticagrelor

As of the latest FDA labeling reviewed, Ticagrelor (TICAGRELOR) does not carry a black box warning. Standard warnings and precautions still apply — see the full Ticagrelor medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Dyspnea was reported more frequently with ticagrelor than with control agents in clinical trials. Dyspnea from ticagrelor is self-limiting. ( 5.3 ) •Severe Hepatic Impairment: Likely increase in exposure to ticagrelor. ( 5.5 ) •Laboratory Test Interference: False negative platelet functional test results have been reported for Heparin Induced Thrombocytopenia (HIT). Ti

No black box warning on record for Ticagrelor

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Dyspnea was reported more frequently with ticagrelor than with control agents in clinical trials. Dyspnea from ticagrelor is self-limiting. ( 5.3 ) •Severe Hepatic Impairment: Likely increase in exposure to ticagrelor. ( 5.5 ) •Laboratory Test Interference: False negative platelet functional test results have been reported for Heparin Induced Thrombocytopenia (HIT). Ti

Ticagrelor Black Box Warning

No black box warning on record for Ticagrelor

Other warnings & precautions

Ticagrelor Black Box Warning

No black box warning on record for Ticagrelor

Other warnings & precautions